P3 Health Partners (NASDAQ:PIII – Get Free Report) and Tempus AI (NASDAQ:TEM – Get Free Report) are both healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, institutional ownership, analyst recommendations, dividends, risk, earnings and valuation.
Profitability
This table compares P3 Health Partners and Tempus AI’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| P3 Health Partners | -6.55% | N/A | -16.40% |
| Tempus AI | -17.77% | -50.28% | -10.33% |
Valuation & Earnings
This table compares P3 Health Partners and Tempus AI”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| P3 Health Partners | $1.46 billion | 0.02 | -$147.95 million | ($33.00) | -0.13 |
| Tempus AI | $1.27 billion | 11.04 | -$245.03 million | ($1.44) | -54.06 |
P3 Health Partners has higher revenue and earnings than Tempus AI. Tempus AI is trading at a lower price-to-earnings ratio than P3 Health Partners, indicating that it is currently the more affordable of the two stocks.
Analyst Ratings
This is a summary of recent recommendations and price targets for P3 Health Partners and Tempus AI, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| P3 Health Partners | 1 | 2 | 1 | 0 | 2.00 |
| Tempus AI | 2 | 9 | 11 | 0 | 2.41 |
P3 Health Partners presently has a consensus price target of $17.00, suggesting a potential upside of 304.76%. Tempus AI has a consensus price target of $72.47, suggesting a potential downside of 6.89%. Given P3 Health Partners’ higher possible upside, research analysts plainly believe P3 Health Partners is more favorable than Tempus AI.
Insider & Institutional Ownership
7.7% of P3 Health Partners shares are held by institutional investors. Comparatively, 24.2% of Tempus AI shares are held by institutional investors. 10.9% of P3 Health Partners shares are held by insiders. Comparatively, 24.3% of Tempus AI shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Volatility & Risk
P3 Health Partners has a beta of 1.7, indicating that its share price is 70% more volatile than the S&P 500. Comparatively, Tempus AI has a beta of 3.54, indicating that its share price is 254% more volatile than the S&P 500.
Summary
Tempus AI beats P3 Health Partners on 8 of the 14 factors compared between the two stocks.
About P3 Health Partners
P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. P3 Health Partners Inc. was founded in 2020 and is based in Henderson, Nevada.
About Tempus AI
Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO.
Receive News & Ratings for P3 Health Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for P3 Health Partners and related companies with MarketBeat.com's FREE daily email newsletter.
